Sage Journals: Discover world-class research

Open access

Review article

First published 2021

Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention

Kelsey Woods Morgan, Kayla Rena Joyner

Sage Open Medicine

Open access

Research article

First published 2020-3

Eptinezumab in episodic migraine: A randomized,double-blind,placebo-controlled study (PROMISE-1)

Messoud Ashina, Joel Saper, Roger Cady [...]

Cephalalgia

Open access

Research article

First published 2022-9

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine

Peter McAllister, David Kudrow, Roger Cady [...]

Cephalalgia

Open access

Research article

First published 2022

Eptinezumab administered intravenously,subcutaneously,or intramuscularly in healthy subjects and/or patients with migraine: Early development studies

Brian Baker, Vivienne Shen, Roger Cady [...]

Cephalalgia Reports

Open access

Research article

First published 2022-7

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

Messoud Ashina, Peter McAllister, Roger Cady [...]

Cephalalgia

Open access

Research article

First published 2023-5

Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized,placebo-controlled DELIVER study

Messoud Ashina, Michel Lanteri-Minet, Anders Ettrup [...]

Cephalalgia

Open access

Research article

First published 2025

Effectiveness and safety of eptinezumab in anti-CGRP(R) mAbs-naïve and mAbs-non responders’ patients: A retrospective observational study

Alessia Bellotti, Caterina Podella, Paola Sarchielli

Cephalalgia Reports

Free access

Research article

First published 2019-8

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial

David W Dodick, Richard B Lipton, Stephen Silberstein [...]

Cephalalgia

Open access

Research article

First published 2025-10

Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized,double-blind,placebo-controlled SUNRISE trial

Shengyuan Yu, Yasuhiko Matsumori, Byung-Kun Kim [...]

Cephalalgia

Open access

Research article

First published 2024-10

Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study

Paul Triller, Virginia N. Blessing, Lucas H. Overeem [...]

Cephalalgia

Search results